Monica Slavin

Diagnostic Yield of Initial and Consecutive Blood Cultures in Children With Cancer and Febrile Neutropenia.

Gabrielle M Haeusler, Richard De Abreu Lourenco, Hannah Clark, Karin A Thursky, Monica A Slavin, Franz E Babl, Francoise Mechinaud, Frank Alvaro, Julia Clark, Bhavna Padhye, Marianne Phillips, Leanne Super, Heather Tapp, Thomas Walwyn, David Ziegler, Robert Phillips, Leon J Worth

Journal article  |  2021  |  Journal of the Pediatric Infectious Diseases Society

BACKGROUND: The timing and necessity of repeated blood cultures (BCs) in children with cancer and febrile neutropenia (FN) are unk..

Latent infection screening and prevalence in cancer patients born outside of Australia: a universal versus risk-based approach?

Gemma Reynolds, Gabrielle Haeusler, Monica A Slavin, Benjamin Teh, Karin Thursky

Journal article  |  2021  |  Supportive Care in Cancer

PURPOSE: Contention surrounds how best to screen patients for latent and undiagnosed infection prior to cancer treatment. Early tr..

Bispecific antibody therapy, its use and risks for infection: Bridging the knowledge gap.

Anthony P Longhitano, Monica A Slavin, Simon J Harrison, Benjamin W Teh

Journal article  |  2021  |  Blood Reviews

Relapsed haematological malignancies have a poor disease prognosis with current therapies. Bispecific antibodies (BsAbs) are becom..

Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies.

Chhay Lim, Priyadarshini Sinha, Simon J Harrison, Hang Quach, Monica A Slavin, Benjamin W Teh

Journal article  |  2021  |  Clinical Lymphoma Myeloma & Leukemia

INTRODUCTION: Treatment for multiple myeloma (MM) has continued to evolve with second generation immunomodulatory drugs (IMiDs), p..

Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.

Martin Hoenigl, Jon Salmanton-García, Thomas J Walsh, Marcio Nucci, Chin Fen Neoh, Jeffrey D Jenks, Michaela Lackner, Rosanne Sprute, Abdullah MS Al-Hatmi, Matteo Bassetti, Fabianne Carlesse, Tomas Freiberger, Philipp Koehler, Thomas Lehrnbecher, Anil Kumar, Juergen Prattes, Malcolm Richardson, Sanjay Revankar, Monica A Slavin, Jannik Stemler, et al.

Journal article  |  2021  |  The Lancet Infectious Diseases

With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Asp..

Managing low-risk febrile neutropenia in children in the time of COVID-19: What matters to parents and clinicians

Gabrielle M Haeusler, Richard De Abreu Lourenco, Cindy Bakos, Tracey O'Brien, Monica A Slavin, Julia E Clark, Brendan McMullan, Meredith L Borland, Franz E Babl, Meinir Krishnasamy, Marijana Vanevski, Karin A Thursky, Lisa Hall

Journal article  |  2021  |  Journal of Paediatrics and Child Health

AIM: The Australian 'There is no place like home' project is implementing a paediatric low-risk febrile neutropenia (FN) programme..

Quality of inpatient antimicrobial use in hematology and oncology patients.

Abby P Douglas, Lisa Hall, Rodney S James, Leon J Worth, Monica A Slavin, Karin A Thursky, undefined National Antimicrobial Prescribing Survey

Journal article  |  2021  |  Infection Control and Hospital Epidemiology

OBJECTIVES: To compare antimicrobial prescribing practices in Australian hematology and oncology patients to noncancer acute inpat..

The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions.

Ana Copaescu, Effie Mouhtouris, Sara Vogrin, Fiona James, Kyra YL Chua, Natasha E Holmes, Abby Douglas, Monica A Slavin, Heather Cleland, Celia Zubrinich, Ar Kar Aung, Michelle SY Goh, Elizabeth J Phillips, Jason A Trubiano, undefined Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)

Journal article  |  2021  |  The Journal of Allergy and Clinical Immunology In Practice

BACKGROUND: The use of in vivo and ex vivo diagnostic tools for delayed immune-mediated adverse drug reactions is currently ill de..

Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearance

Julian Lindsay, Jad Othman, Ian Kerridge, Keith Fay, William Stevenson, Chris Arthur, Sharon C-A Chen, David CM Kong, Steven A Pergam, Catherine Liu, Monica A Slavin, Matthew Greenwood

Journal article  |  2021  |  Transplant Infectious Disease

BACKGROUND: Cytomegalovirus (CMV) reactivation is a frequent complication after allogeneic hematopoietic cell transplant (alloHCT)..

Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myeloma

Marcel Doerflinger, Alexandra L Garnham, Saskia Freytag, Simon J Harrison, H Miles Prince, Hang Quach, Monica A Slavin, Marc Pellegrini, Benjamin W Teh

Journal article  |  2021  |  Clinical & Translational Immunology

Objectives: Patients with multiple myeloma (MM) are at increased risk for infection. Clinical assessment of infection risk is incr..